Patent Assignment
Reel/Frame 052495/0516
Change of Address
Recorded: 2020-04-24
Pages: 2
Assignor
XU, REN-HE
Executed: 2019-09-05
Assignee
IMSTEM BIOTECHNOLOGY, INC.
400 FARMINGTON AVENUE R1808, FARMINGTON, CONNECTICUT, 06030
Covered Properties
(3)
Mesenchymal-Like Stem Cells Derived from Human Embryonic Stem Cells, Methods and Uses Thereof
Using mesenchymal-like stem cells derived from human embryonic stem cell-differentiated hemangioblast to treat multiple sclerosis and other autoimmune diseases
Application:
61/670,787 →
Methods for identify highly immunosuppressive human embryonic stem derived mesenchymal-like stem cells and improve immunosuppressive function mesenchymal and mesenchymal-like stem cells
Application:
61/762,961 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 20, 2017
From: WANG, XIAOFANG
To: IMSTEM BIOTECHNOLOGY, INC.
Reel/Frame 042084/0509 →
Assignment of Assignor's Interest
Sep 5, 2019
From: XU, REN-HE
To: IMSTEM BIOTECHNOLOGY, INC.
Reel/Frame 050281/0972 →
Assignment of Assignor's Interest
Jun 2, 2023
From: IMSTEM BIOTECHNOLOGY, INC.
To: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Reel/Frame 063845/0649 →
Assignment of Assignor's Interest
Sep 18, 2023
From: LANZA, ROBERT; KIMBREL, ERIN
To: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Reel/Frame 064938/0064 →